Immunohistochemical status of the p53 protein and Ki-67 antigen using biopsied specimens can predict a sensitivity to neoadjuvant therapy in patients with esophageal cancer. - Kitamura,K.; Saeki,H.; Kawaguchi,H. (Hepatogastroenterology, 2000)